The increase in global disease and pandemics, the threat of antibiotic resistance, the strain inflicted on our healthcare systems by an aging population – these are just some of the health-related challenges facing our global society.

All this comes at a time of rapid improvement in the speed and accuracy of diagnostics, for example with precision and targeted treatments of cancers. However, the cost of the healthcare varies greatly from country to country, bringing disparity in the equality of access to these medical advances.

This generates a real opportunity to improve health and medical technologies that will benefit all, through a data driven approach in which individual treatment is based on personal data or DNA.

Our research

Warwick is strongly positioned in Health and Medical Technology. Our research addresses global health challenges to counter the most powerful drivers of human illness and disease, such as:

• Antibiotic resistance
• Increasing prevalence of risk factors causing cardiovascular and neoplastic diseases
• Future pandemics
• Insecticide resistance of disease vectors
• Societal ageing

Our work along the entire value chain, from fundamental discovery to industry collaboration and commercial application, is rarely paralleled on a national or international level.

Notably, we are increasing the applicability and affordability of treatments for less privileged countries and regions, and our research on new molecules, materials and related technologies will advance therapeutic impact in reconstructive and regenerative medicine.

This research trajectory benefits markedly from interdisciplinary work and underlines the positive impact of Warwick’s research on major healthcare challenges. It also provides abundant options for public outreach.